Avoid common mistakes on your manuscript.
Dear Editor,
Children with acute respiratory failure may benefit from the use of high-frequency oscillation ventilation (HFOV) [1]. When HFOV fails to stabilise respiratory function, many children are transported to specialised centres for extracorporeal membrane oxygenation (ECMO) [2–5]. HFOV during patient transport represents not only a logistical challenge (see Electronic Supplementary Material) to the pediatric intensive care unit transport team (PICU-TT), but also a severe physiological challenge to the child receiving it.
For more than 20 years the PICU-TT at the Hôpital Robert Debré (Paris, France) has been the only French PICU-TT to use HFOV during the transport of children for subsequent ECMO support. The transport of patients on ECMO started in the region at the end of 2014. Here, we report our experience with the use of HFOV during the transport of pediatric patients for ECMO support and hypothesize that, when using a proportional hazard survival model, pre-transport physical or transport parameters were not associated with mortality.
Fifty-nine children with respiratory failure, deteriorating HFOV ventilation and/or haemodynamics were provided with HFOV during transport for ECMO support during the study period (January 1994–December 2014). Approval for the retrospective study was given by the Hospital Institutional Review Board. All transfers were by road and occurred in the Paris Region, with 57 children transported to Hôpital Trousseau and two children transported to Hôpital Robert Debré. Patient selection criteria were neither standardised nor defined by the referral or ECMO centres and were independent of the PICU-TT.
The children ranged in age and weight from 0 days to 9 years and from 2.3 to 25 kg, respectively. The principal diagnoses of the transported children were diaphragmatic hernia (17 children), acute respiratory distress syndrome (15), meconium inhalation (11), pneumothoraces (5), sepsis (5) and other diagnoses (6). Twenty-seven children were transported using a SensorMedics oscillatory ventilator (SensorMedics Corp., San Diego, CA) and 32 using a SLE ventilator (SLE Ltd., South Croydon, UK). The transport distances ranged from 5 to 242 km.
Thirty-one children (53 %) survived to discharge, and five children (8.5 %) died during transport, none as a result of equipment malfunction. The median time to death for the 59 children was 14 (range 1–26) days. One child died shortly after arrival and was not connected to ECMO. Of the remaining 53 children, 36 (68 %) were connected to the ECMO circuit. The physical and transport parameters of these children on arrival of the PICU-TT are presented in Table 1. The blood oxygen saturation (SpO2) of the five children who died during transport ranged from 30 to 71 % prior to transport.
Boedy et al. [5] have suggested that the ECMO mortality data reported to date have been influenced by survival bias, with deaths before and during transport being ‘hidden’. We also observed a significant early mortality in our study. In contrast, in their study of 112 children transported on ECMO, Clement et al. [2] described two deaths prior to arrival of the PICU-TT and one child ‘beyond salvage’ upon arrival of the team; however, they did not describe any deaths during transport. In both our study and that of Clement et al. [2] the criteria for transfer were not predefined and, consequently, a comparison of death rates is difficult. An important advantage of the use of HFOV during the transport of children for ECMO is that not all the children in our study subsequently required ECMO.
In conclusion, the use of HFOV during the transport of children for ECMO in children is feasible. HFOV during transport may reduce the overall numbers of children being connected to ECMO, but early mortality in severely hypoxaemic children may be higher. Until inclusive risk-adjusted data are available, the use of HFOV during transport is an option, especially where a mobile ECMO team is unavailable.
References
Fioretto JR, Batista KA, Carpi MF, Bonatto RC, Moraes MA, Ricchetti SM, Batistella RF (2011) High-frequency oscillatory ventilation associated with inhaled nitric oxide compared to pressure-controlled assist/control ventilation and inhaled nitric oxide in children: randomized, non-blinded, crossover study. Pediatr Pulmonol 46:809–816. doi:10.1002/ppul.21452
Clement KC, Fiser RT, Fiser WP, Chipamn CW, Taylor B, Heulitt MJ, Moss M, Fasules JW, Faulkner SC, Imamura M, Fortenot EE, Jaquiss R (2010) Single-institution experience with interhospital extracorporeal membrane oxygenation transport: a descriptive study. Pediatr Crit Care Med 11:509–513. doi:10.1097/PCC.0b013e3181c515ca
Cornish JD, Carter JM, Gerstmann DR, Null DM (1991) Extracorporeal membrane oxygenation as a means of stabilizing and transporting high risk neonates. Trans Am Soc Artif Intern Organs 37:564–568
McBride LR, Lowdermilk GA, Fiore AC, Moroney DA, Brannan JA (2000) Transfer of patients receiving advanced mechanical circulatory support. J Thorac Cardiovasc Surg 119:1015–1020
Boedy RF, Howell CG, Kanto WP (1990) Hidden mortality rate associated with extracorporeal membrane oxygenation. J Pediatr 117:462–464
Conflicts of interest
Peter Jones is an Honorary Lecturer at the Portex Unit Institute of Child Health, University College London which receives a proportion of its funding from the UK Department of Health’s NIHR Biomedical Research Centre Funding Scheme and Smiths Medical Ltd. In 2014, Peter Jones received a contribution from Orbees Medical towards costs for research into haemodynamics during intubation. None of the above funding was for this specific study. None of the other authors have conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Jones, P., Dauger, S., Leger, PL. et al. Mortality in children with respiratory failure transported using high-frequency oscillatory ventilation. Intensive Care Med 41, 1363–1364 (2015). https://doi.org/10.1007/s00134-015-3808-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-015-3808-z